BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-251

  1. 1,771 Posts.
    lightbulb Created with Sketch. 190
    well said NT, and I’m going to go on the record (regardless of how bonkers it sounds) and say that I see zero benefit in any sale to any ‘BIG PHARMA’ at any point in time. There is too much money in existing chemical based treatments being peddled out currently most of which, as we know, are blighted by some horrible side effects. BIG PHARMA imho, are terrified of anybody unlocking the secret to, what is essentially, a ‘one plant cures all’ solution. For the Zeneca’s, Pfizer’s and J&J’s of this world, the emergence of a synthetic efficient, what appears to be devoid of side- effects plant derived treatment must be viewed as a catastrophic outcome.
    BIG PHARMA, will, IMO, buy in so as to suppress the emergence of a patented synthetic CBD wonder drug.
    Vince needs to take the majors head on here.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.010(2.63%)
Mkt cap ! $669.7M
Open High Low Value Volume
38.0¢ 38.5¢ 36.5¢ $2.548M 6.766M

Buyers (Bids)

No. Vol. Price($)
2 96148 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 782479 9
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.